Quad Technologies has partnered with the University of Massachusetts Medical School in a study to evaluate the performance of its novel cell separation technology for the enrichment and purification of CD3+ T-cells from human umbilical cord blood.
See the press release for more about the results. Woburn-based Quad Technologies is a former member of North Shore InnoVentures.
Leave a Comment